GlassScriptPhysician profile
Roger D Wilt
NPI 1801873013
$864.97
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $742 · 2020: $122.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $141.82 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $128.73 | 2019-2020 | |
| Amarin Pharma, INC. | $57.90 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.58 | 2019 | |
| Janssen Pharmaceuticals, INC | $44.74 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $43.44 | 2019-2020 | |
| Novo Nordisk INC | $40.73 | 2019-2020 | |
| Shire North American Group INC | $39.86 | 2019 | |
| Glaxosmithkline, LLC. | $34.41 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.31 | 2019 | |
| Astellas Pharma US INC | $30.63 | 2019 | |
| Boston Scientific Corporation | $24.32 | 2019 | |
| Arbor Pharmaceuticals, INC. | $24.26 | 2019 | |
| Allergan, INC. | $22.15 | 2019-2020 | |
| Mylan Specialty L.P. | $19.40 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $18.99 | 2019 | |
| Genentech USA, INC. | $18.79 | 2019 | |
| Valeritas, INC. | $18.39 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.07 | 2019 | |
| Sanofi Pasteur INC. | $16.37 | 2019 | |
| Avanir Pharmaceuticals, INC. | $14.75 | 2019 | |
| Merck Sharp & Dohme LLC | $13.27 | 2019 | |
| Pfizer INC. | $11.06 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Wilt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.